13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

Page 2 of 9 – SEC Filing


Schedule 13D

CUSIP No. 00484M106
  (1)    

Name of
Reporting Persons:

Scopia Capital Management LP

  (2)

Check the Appropriate Box if a Member
of a Group (See Instructions):

(a)  ☐        (b)  ☐

  (3)

SEC Use Only:

  (4)

Source of Funds (See
Instructions):

AF

  (5)

Check if Disclosure of Legal
Proceedings is Required Pursuant to Items 2(d) or 2(e):  ☐

  (6)

Citizenship or Place of
Organization:

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

  (7) 

Sole Voting Power

0

  (8)

Shared Voting Power

8,474,728

  (9)

Sole Dispositive Power

0

(10)

Shared Dispositive Power

8,474,728

(11)    

Aggregate Amount Beneficially Owned by Each Reporting Person:

8,474,728

(12)

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares (See Instructions):  ☐

(13)

Percent of Class Represented by Amount
in Row (11):

18.1%*

(14)

Type of Reporting Person (See
Instructions):

PN, IA

* Based on 46,913,767 shares of Common Stock of Acorda Therapeutics, Inc. (the Issuer) outstanding as of February 20, 2018, based on information provided by the Issuer.

Follow Acorda Therapeutics Inc. (NASDAQ:ACOR)